Propoxyphene Napsylate
Generic Name: propoxyphene napsylate
Manufactured by WATSON LABS FLORIDA. Dosage form: TABLET. Route: ORAL. Active ingredients: ACETAMINOPHEN (650MG); PROPOXYPHENE NAPSYLATE (100MG). Application: ANDA076609.
Overview
Manufactured by WATSON LABS FLORIDA. Dosage form: TABLET. Route: ORAL. Active ingredients: ACETAMINOPHEN (650MG); PROPOXYPHENE NAPSYLATE (100MG). Application: ANDA076609.
Dosage
Available as tablet for oral use.
Related Medications
Dried Aluminum Hydroxide Gel
dried aluminum hydroxide gel
Dosage form: GEL. Active ingredients: ALUMINUM HYDROXIDE (80 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.
Benzocaine, Lidocaine, Tetracaine
benzocaine, lidocaine, tetracaine
Standardized Chemical Allergen [EPC]
Purpose Topical anesthetic
Cytarabine
cytarabine
Nucleoside Metabolic Inhibitor [EPC]
DESCRIPTION Cytarabine Injection, an antineoplastic, is a sterile solution of cytarabine for intravenous, intrathecal or subcutaneous administration. Each mL contains 100 mg Cytarabine (100 mg/mL) in a 20 mL single dose vial (2 g/20 mL). Cytarabine Injection 2 g/20 mL is a sterile solution for intravenous, intrathecal or subcutaneous administration. Each mL contains 100 mg Cytarabine, USP, and the following inactive ingredients: Water for Injection q.s.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.